EUVIMEDEUVIMED entdecken
Crossref

Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study

Lizhong Yin, Jing Wang, Bin Zhang, Wenli Wang, Bin Yu

Fetal Diagnosis and Therapy · 2024

DOI: 10.1159/000542147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2024. Verfasst von Lizhong Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou,…. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Microarray Analysis, Chromosome Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chromosomal microarray analysis (CMA) can identify clinically significant microdeletions and microduplications, providing valuable insights into the genetic basis of various disorders. Our study was to evaluate clinical management and prognosis of fetuses with prenatal variants of unknown significance (VOUS) and determine diagnostic approaches for subsequent pregnancies.

Methods

This study included 2,953 fetuses undergoing CMA at the Prenatal Diagnostic Center of Changzhou Maternal and Child Health Care Hospital from January 2018 to December 2022, identifying 162 cases with VOUS. Parent-of-origin testing determined the origin of copy number variations. Prenatal genetic counseling was provided, and outcomes were followed for 3–36 months post-birth.

Results

All 162 VOUS cases received prenatal genetic counseling. Among these, 123 continued the pregnancy; 22 chose termination, and 17 were lost to follow-up. Of the continuations, 116 delivered at term and 7 preterm. Post-birth follow-up showed 5/123 live-born fetuses developed relevant clinical phenotypes. Parent-of-origin testing in 21 cases identified 18 hereditary and 3 de novo variants. Additionally, five subsequent pregnancies were monitored, with two undergoing amniocentesis and three receiving low-risk noninvasive prenatal testing, all with positive outcomes.

Conclusion

VOUS, occurring in approximately 5% of cases, require comprehensive prenatal genetic counseling and show generally favorable outcomes. Despite low association with adverse clinical phenotypes, the importance of postnatal follow-up and regular report updates is emphasized to detect potential clinical associations early.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal DiagnosisMicroarray AnalysisChromosome DisordersHumansFemalePregnancyAdultGenetic CounselingDNA Copy Number VariationsGenetic TestingInfant, NewbornPregnancy Outcome

Stichwörter der Autor:innen

Chromosomal microarray analysisKaryotypingPrenatal diagnosisVariants of unknown significance

Autor:innen und Institutionen

  • Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou, China.

Zitieren

APA

Yin, L., Wang, J., Zhang, B., Wang, W., & Yu, B. (2024). Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000542147

Vancouver

Yin L, Wang J, Zhang B, Wang W, Yu B. Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study. Fetal Diagnosis and Therapy. 2024. doi:10.1159/000542147

BibTeX
@article{Yin2024,
  author = {Yin, Lizhong and Wang, Jing and Zhang, Bin and Wang, Wenli and Yu, Bin},
  title = {Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study},
  journal = {Fetal Diagnosis and Therapy},
  year = {2024},
  doi = {10.1159/000542147}
}
Kostenlos starten →